Data for: A phase Ib/II single-blinded, randomised, controlled study to determine safety, immunogenicity and efficacy of the candidate Coronavirus Disease (COVID-19) vaccine ChAdOx1 nCoV-19 in adults in Kenya
<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a research archivist expert in dataset metadata. Answer the question truthfully.  <|eot_id|><|start_header_id|>user<|end_header_id|> Here is the Description of a dataset. Description:'The dataset contains information on demographics, safety and immunogenicity collected to evaluate whether the ChAdOx1 nCoV-19 vaccine is safe, elicits good immune responses and protects Kenyan adults from COVID19. The persistence of these immune responses was investigated up to 12 months following immunization with a single dose of vaccine at Day 0 and booster dose at Day 84 post first dose. A Data Management team was located at KEMRI CGMRC with data collection using eCRFs/CRFs by designated staff. Clinician/data entry clerks/trained study team members used password-protected computers. Data was entered onto an electronic database. This was done via a secure web interface with data checks used during data entry to ensure data quality. The database was activated for the study only after successfully passing a formal design and test pr' . Please return only a json list of at most 3 Keywords corresponding to the Description:.<|eot_id|><|start_header_id|>assistant<|end_header_id|> {"Answer" : ["COVID-19","SARS-COV-2","Vaccine"]} <|eot_id|>
 Here is the Description of a dataset. Description:'The dataset contains information on demographics, safety and immunogenicity collected to evaluate whether the ChAdOx1 nCoV-19 vaccine is safe, elicits good immune responses and protects Kenyan adults from COVID19. The persistence of these immune responses was investigated up to 12 months following immunization with a single dose of vaccine at Day 0 and booster dose at Day 84 post first dose. A Data Management team was located at KEMRI CGMRC with data collection using eCRFs/CRFs by designated staff. Clinician/data entry clerks/trained study team members used password-protected computers. Data was entered onto an electronic database. This was done via a secure web interface with data checks used during data entry to ensure data quality. The database was activated for the study only after successfully passing a formal design and test pr' . Please return only a json list of at most 3 Keywords corresponding to the Description:.
The dataset contains information on demographics, safety and immunogenicity collected to evaluate whether the ChAdOx1 nCoV-19 vaccine is safe, elicits good immune responses and protects Kenyan adults from COVID19. The persistence of these immune responses was investigated up to 12 months following immunization with a single dose of vaccine at Day 0 and booster dose at Day 84 post first dose. A Data Management team was located at KEMRI CGMRC with data collection using eCRFs/CRFs by designated staff. Clinician/data entry clerks/trained study team members used password-protected computers. Data was entered onto an electronic database. This was done via a secure web interface with data checks used during data entry to ensure data quality. The database was activated for the study only after successfully passing a formal design and test pr
COVID-19; SARS-COV-2; Vaccine